(1)
Moore, K. T.; Langas, M. Use of Rivaroxaban and Apixaban, Two Non-Vitamin K Antagonist Oral Anticoagulants (NOACs), in Renally Impaired Patients - the Limits of Our Knowledge.
J Cardiol Cardiovasc Med
2018
,
3
, 049-051.